Bridgeway Capital Management’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $280K | Hold |
189,100
| – | – | 0.01% | 881 |
|
|
2025
Q1 | $484K | Buy |
189,100
+7,700
| +4% | +$19.7K | 0.01% | 750 |
|
|
2024
Q4 | $341K | Sell |
181,400
-2,390
| -1% | -$4.49K | 0.01% | 896 |
|
|
2024
Q3 | $187K | Hold |
183,790
| – | – | ﹤0.01% | 1080 |
|
|
2024
Q2 | $215K | Hold |
183,790
| – | – | 0.01% | 1049 |
|
|
2024
Q1 | $232K | Sell |
183,790
-25,000
| -12% | -$31.5K | ﹤0.01% | 1078 |
|
|
2023
Q4 | $372K | Buy |
208,790
+50,000
| +31% | +$89K | 0.01% | 1013 |
|
|
2023
Q3 | $264K | Hold |
158,790
| – | – | 0.01% | 1036 |
|
|
2023
Q2 | $318K | Buy |
158,790
+25,000
| +19% | +$50K | 0.01% | 1032 |
|
|
2023
Q1 | $281K | Hold |
133,790
| – | – | 0.01% | 1030 |
|
|
2022
Q4 | $183K | Hold |
133,790
| – | – | ﹤0.01% | 1103 |
|
|
2022
Q3 | $139K | Sell |
133,790
-25,000
| -16% | -$26K | ﹤0.01% | 1215 |
|
|
2022
Q2 | $173K | Buy |
158,790
+130,000
| +452% | +$142K | ﹤0.01% | 1121 |
|
|
2022
Q1 | $31K | Buy |
+28,790
| New | +$31K | ﹤0.01% | 1301 |
|
|
2021
Q4 | – | Sell |
-58,890
| Closed | -$78K | – | 1318 |
|
|
2021
Q3 | $78K | Sell |
58,890
-335,000
| -85% | -$444K | ﹤0.01% | 1262 |
|
|
2021
Q2 | $752K | Buy |
393,890
+91,299
| +30% | +$174K | 0.01% | 949 |
|
|
2021
Q1 | $1.35M | Buy |
302,591
+90,000
| +42% | +$402K | 0.03% | 759 |
|
|
2020
Q4 | $772K | Hold |
212,591
| – | – | 0.02% | 808 |
|
|
2020
Q3 | $823K | Buy |
212,591
+38,300
| +22% | +$148K | 0.02% | 733 |
|
|
2020
Q2 | $661K | Buy |
174,291
+84,799
| +95% | +$322K | 0.01% | 777 |
|
|
2020
Q1 | $210K | Buy |
+89,492
| New | +$210K | ﹤0.01% | 1047 |
|
|
2019
Q4 | – | Sell |
-20,259
| Closed | -$42K | – | 1373 |
|
|
2019
Q3 | $42K | Hold |
20,259
| – | – | ﹤0.01% | 1283 |
|
|
2019
Q2 | $95K | Hold |
20,259
| – | – | ﹤0.01% | 1247 |
|
|
2019
Q1 | $89K | Hold |
20,259
| – | – | ﹤0.01% | 1286 |
|
|
2018
Q4 | $63K | Hold |
20,259
| – | – | ﹤0.01% | 1330 |
|
|
2018
Q3 | $147K | Hold |
20,259
| – | – | ﹤0.01% | 1353 |
|
|
2018
Q2 | $87K | Sell |
20,259
-10,000
| -33% | -$42.9K | ﹤0.01% | 1372 |
|
|
2018
Q1 | $163K | Hold |
30,259
| – | – | ﹤0.01% | 1288 |
|
|
2017
Q4 | $200K | Hold |
30,259
| – | – | ﹤0.01% | 1276 |
|
|
2017
Q3 | $176K | Hold |
30,259
| – | – | ﹤0.01% | 1297 |
|
|
2017
Q2 | $253K | Hold |
30,259
| – | – | ﹤0.01% | 1240 |
|
|
2017
Q1 | $412K | Hold |
30,259
| – | – | 0.01% | 1123 |
|
|
2016
Q4 | $135K | Hold |
30,259
| – | – | ﹤0.01% | 1347 |
|
|
2016
Q3 | $169K | Hold |
30,259
| – | – | ﹤0.01% | 1344 |
|
|
2016
Q2 | $194K | Sell |
30,259
-4,696
| -13% | -$30.1K | ﹤0.01% | 1308 |
|
|
2016
Q1 | $294K | Hold |
34,955
| – | – | ﹤0.01% | 1218 |
|
|
2015
Q4 | $357K | Hold |
34,955
| – | – | 0.01% | 1161 |
|
|
2015
Q3 | $412K | Buy |
34,955
+2,221
| +7% | +$26.2K | 0.01% | 1119 |
|
|
2015
Q2 | $638K | Buy |
32,734
+2,651
| +9% | +$51.7K | 0.01% | 955 |
|
|
2015
Q1 | $535K | Buy |
30,083
+5,202
| +21% | +$92.5K | 0.01% | 1074 |
|
|
2014
Q4 | $458K | Buy |
24,881
+4,881
| +24% | +$89.8K | 0.01% | 1105 |
|
|
2014
Q3 | $484K | Buy |
+20,000
| New | +$484K | 0.01% | 1085 |
|